M/Z: 761.4586
Hit 3 annotations: PA(16:1(9Z)/6 keto-PGF1alpha)_[M+H]+
; PS(14:1(9Z)/18:2(10E,12Z)+=O(9))_[M+NH4]+
; Soyasaponin III_[M+H-2H2O]+
- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 30 Reference Ions Near m/z 761.4586
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000006052 Reliable | 761.4534 | 761.4532 ~ 761.4537 MzDiff: 1.8 ppm |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
22.3 (100%) | Rattus norvegicus [UBERON:0004358] caput epididymis |
MSI_000063193 Reliable | 761.4516 | 761.4514 ~ 761.4517 MzDiff: 1.4 ppm |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
1.44 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000061286 Unreliable | 761.4533 | 761.4532 ~ 761.4536 MzDiff: 1.7 ppm |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
1.8 (67%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000009009 Unreliable | 761.461 | 761.461 ~ 761.461 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
3.15 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000009020 Unreliable | 761.453 | 761.453 ~ 761.453 MzDiff: none |
(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one (BioDeep_00002074325) Formula: C36H59N9O7S (761.4258) |
3.15 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000021336 Unreliable | 761.4564 | 761.4564 ~ 761.4564 MzDiff: none |
PS(14:1(9Z)/18:2(10E,12Z)+=O(9)) (BioDeep_00000205948) Formula: C38H66NO11P (743.4373) |
1.08 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000021795 Unreliable | 761.451 | 761.451 ~ 761.451 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
0.64 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000058612 Unreliable | 761.4517 | 761.4516 ~ 761.4519 MzDiff: 1.2 ppm |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
1.43 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000000825 Unavailable | 761.461 | 761.461 ~ 761.461 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
-0.62 (100%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000000833 Unavailable | 761.453 | 761.453 ~ 761.453 MzDiff: none |
(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one (BioDeep_00002074325) Formula: C36H59N9O7S (761.4258) |
-0.62 (100%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000002421 Unreliable | 761.4513 | 761.4513 ~ 761.4513 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
1.44 (100%) | Rattus norvegicus [UBERON:0001950] neocortex |
MSI_000003236 Unreliable | 761.4513 | 761.4513 ~ 761.4513 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
0.63 (100%) | Rattus norvegicus [UBERON:0002037] cerebellum |
MSI_000005358 Unavailable | 761.4513 | 761.4513 ~ 761.4513 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
-1.18 (100%) | Rattus norvegicus [UBERON:0002298] brainstem |
MSI_000006011 Unavailable | 761.4513 | 761.4513 ~ 761.4513 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
-1.35 (100%) | Rattus norvegicus [UBERON:0002435] striatum |
MSI_000023142 Unreliable | 761.451 | 761.451 ~ 761.451 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
0.53 (100%) | Mus musculus [UBERON:0004250] upper arm bone |
MSI_000026648 Unreliable | 761.4559 | 761.4559 ~ 761.4559 MzDiff: none |
Not Annotated | 1.79 (0%) | Mus musculus [UBERON:0002048] lung |
MSI_000027798 Unreliable | 761.4661 | 761.4661 ~ 761.4661 MzDiff: none |
Not Annotated | 2.04 (0%) | Mus musculus [UBERON:0002048] lung |
MSI_000028919 Unreliable | 761.4639 | 761.4639 ~ 761.4639 MzDiff: none |
PA(18:2(9Z,11Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000188961) Formula: C43H69O9P (760.4679) |
0.17 (100%) | Macropus giganteus [UBERON:0001891] midbrain |
MSI_000029797 Unavailable | 761.4512 | 761.4512 ~ 761.4512 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
-0.25 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000030610 Unreliable | 761.4586 | 761.4586 ~ 761.4586 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
1.43 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000030848 Unreliable | 761.4512 | 761.4512 ~ 761.4512 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
0.81 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000031132 Unreliable | 761.4512 | 761.4512 ~ 761.4512 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
2.33 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000031223 Unreliable | 761.4586 | 761.4586 ~ 761.4586 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
1.78 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000031764 Unavailable | 761.4639 | 761.4639 ~ 761.4639 MzDiff: none |
PA(18:2(9Z,11Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000188961) Formula: C43H69O9P (760.4679) |
-0.11 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000044176 Unreliable | 761.4521 | 761.4521 ~ 761.4521 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
0.82 (100%) | Rattus norvegicus [UBERON:0002264] olfactory bulb |
MSI_000059982 Unavailable | 761.4519 | 761.4519 ~ 761.4519 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
-0.78 (100%) | Mus musculus [UBERON:0002298] brainstem |
MSI_000060610 Unavailable | 761.4519 | 761.4519 ~ 761.4519 MzDiff: none |
Soyasaponin III (BioDeep_00000001008) Formula: C42H68O14 (796.4609) |
-0.35 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
MSI_000061623 Unavailable | 761.4659 | 761.4659 ~ 761.4659 MzDiff: none |
Not Annotated | -0.35 (0%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000062147 Unreliable | 761.4536 | 761.4536 ~ 761.4536 MzDiff: none |
PA(16:1(9Z)/6 keto-PGF1alpha) (BioDeep_00000188394) Formula: C39H69O12P (760.4526) |
0.65 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000062334 Unavailable | 761.4659 | 761.4659 ~ 761.4659 MzDiff: none |
Not Annotated | -0.35 (0%) | Mus musculus [UBERON:0001950] neocortex |
Found 9 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
PA(16:1(9Z)/6 keto-PGF1alpha) Formula: C39H69O12P (760.4526) Adducts: [M+H]+ (Ppm: 1.4) |
Mus musculus (Urinary bladder) |
HR2MSI_mouse_urinary_bladder - S096Resolution: 10μm, 260x134
Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset) |
|
PS(14:1(9Z)/18:2(10E,12Z)+=O(9)) Formula: C38H66NO11P (743.4373) Adducts: [M+NH4]+ (Ppm: 19.4) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
m/z_761.4574 Formula: - (n/a) Adducts: (Ppm: 0) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
m/z_761.4559 Formula: - (n/a) Adducts: (Ppm: 0) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Soyasaponin III Formula: C42H68O14 (796.4609) Adducts: [M+H-2H2O]+ (Ppm: 5.6) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
m/z_761.4576 Formula: - (n/a) Adducts: (Ppm: 0) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
PA(16:1(9Z)/6 keto-PGF1alpha) Formula: C39H69O12P (760.4526) Adducts: [M+H]+ (Ppm: 1.7) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
PA(16:1(9Z)/6 keto-PGF1alpha) Formula: C39H69O12P (760.4526) Adducts: [M+H]+ (Ppm: 5.5) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
PA(16:1(9Z)/6 keto-PGF1alpha) Formula: C39H69O12P (760.4526) Adducts: [M+H]+ (Ppm: 8.3) |
Mus musculus (brain) |
Brain01_Bregma1-42_02_centroidResolution: 17μm, 434x258
|
|